Today's News | Note: News feeds may no longer be available for the articles on this page.

Inovio, NIH to develop swine flu vaccine 11:22 AM 8/10/2009
Reuters
DNA-based vaccine maker Inovio Biomedical Corp will jointly develop universal influenza vaccines with the National Institutes of Health's (NIH) research unit. ...

Flu drugs little use for children, experts say 6:42 AM 8/10/2009
Reuters
Clinical data from past seasonal flu outbreaks showing scant benefits and potentially harmful side effects. ...

Biota's flu drug succeeds in late-stage Asia trial 5:52 AM 8/10/2009
Reuters
Australian biotech firm Biota said a Phase III trial on 1,000 adult patients in east Asia proved to treat symptoms and kill fever in the most common seasonal flu strains with a lower dose than Tamiflu. ...

Amgen says Vectibix colon cancer trial meets goal 5:02 PM 8/6/2009
Reuters
Amgen Inc said colon cancer patients lived significantly longer without their disease getting worse when treated initially with Vectibix and chemotherapy. ...

Baxter completes first swine flu vaccine batches 5:53 AM 8/6/2009
Reuters
Baxter International completed its first commercial batches of H1N1 vaccine in late July. The Celvapan swine flu vaccine is not intended for sale in the United States. ...

Merck, Schering in $41.5 mln drugs settlement 2:54 PM 8/5/2009
Reuters
Merck & Co and Schering-Plough Corp will pay $41.5 million to settle class-action lawsuits over their shared cholesterol drugs Vytorin and Zetia. They disclosed about 145 such lawsuits pending in federal court in New Jersey. ...

Microsoft Slammed Over Bing's Sponsored Online Drug Ads 8:58 AM 8/5/2009
PC World
Microsoft uses an auction system to sell text ads related to search terms without verifying that the sites are legal. ...

Celgene cancer drug may have less heart toxicity 8:50 AM 8/5/2009
Reuters
Celgene Corp said pooled results of its Amrubicin drug in relapsed small cell lung cancer showed it might be less toxic. ...

US panel backs plan for ViroPharma drug copies 8:41 AM 8/5/2009
Reuters
US advisers backed the US FDA guideline for testing less costly generic versions of the antibiotic Vancocin (vancomycin). Manufacturer ViroPharma Inc objected. ...

Novavax says can ready H1N1 vaccine within 11 weeks 8:39 AM 8/5/2009
Reuters
Novavax Inc said it can manufacture its vaccine candidate for the new strain of H1N1 influenza virus within 11 weeks of receiving the gene sequence from the US Centers for Disease Control (CDC). ...

Novartis ships seasonal flu vaccine to US early 5:48 AM 8/5/2009
Reuters
The swine flu pandemic is likely to trigger a rise in demand and the early delivery of Fluvirin will allow public health officials to begin the vaccination campaign ahead of schedule. ...

FDA approves Kowa cholesterol-lowering drug 1:06 PM 8/4/2009
Bizjournals.com
Cholesterol-lowering drug co-developed at the Kowa Research Institute has been approved by the US FDA. Livalo (pitavastatin) can be used for the primary treatment of hypercholesterolemia and combined dyslipidemia. ...

US FDA: Arthritis drugs raise cancer risk in kids 12:59 PM 8/4/2009
Reuters
Anti-TNF drugs used to treat rheumatoid arthritis and other conditions can increase the risk of potentially deadly cancer in children and teens. They include Johnson & Johnson's Simponi (golimumab), Remicade (infliximab), Abbott's Humira (adalimumab), UCB's Cimzia (certolizumab pegol), and Amgen/Wyeth's Enbrel (etanercept). ...

Big drugmakers start trials of swine flu vaccines 12:08 PM 8/4/2009
Reuters
Novartis has started human testing of H1N1 swine flu vaccine candidates. Sanofi-Aventis will start testing this week. GlaxoSmithKline will initiate clinical studies later this month. ...

Acorda shares fall on 2Q results, data on MS drug 10:40 AM 8/4/2009
Forbes
Acorda Therapeutics Inc reported a wider-than-expected second-quarter loss and updated findings for its multiple sclerosis drug candidate Fampridine-SR. ...

<- Day Earlier | Today's News